Trial · NCT07740967
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Joint pain under 3 conditions as measured by a 100 mm visual analogue scale (VAS) | 8 weeks | Participants will place a vertical line on the VAS (ranging from no pain (0 mm) to unbearable pain (100 mm)) which will be measured and recorded. Participants will complete a separate VAS for each of the 3 conditions: after standing rest, after 5 body weight squats, and in response to pain levels during daily activities in the last week (such as walking, getting up from chairs, exercising). |
| Secondary | Hand grip strength dynamometry (kg) | 8 weeks | Hand grip strength will be assessed following the Southampton Protocol, where 3 measures will be taken for each hand. |
| Secondary | Blood pressure (mmHg) | 8 weeks | After 10 minutes of seated rest, 3 blood pressure readings will be taken and recorded using an automated cuff. |
| Secondary | Fatigue under 2 conditions measured by a 100 mm visual analogue scale (VAS) | 8 weeks | Participants will place a vertical line on the scale (ranging from no fatigue at all (0 mm) to extremely fatigued (100 mm)) which will be measured and recorded. Participants will complete a visual analogue scale for 2 conditions: right now, and during daily activities in the last week (such as walking, getting up from chairs, exercising). |
| Secondary | Sleep quality measured by an Athens Insomnia Scale | 8 weeks | The Athens Insomnia Scale is an 8-point questionnaire where participants rank different aspects of their sleep (sleep induction, awakenings during the night, final awakening, total sleep duration, overall sleep quality, sense of wellbeing during the day, functioning during the day, and sleepiness during the day) provided that it occurred at least 3 times in the last week from 0 (no issue) to 3 (serious issue). A lower total score indicates better sleep. |
| Secondary | Simple Sleep Quality Scale | 8 weeks | The simple Sleep Quality Scale asks the following question 'During the past 7 days, how would you rate your sleep quality overall?'. Participants select a number from 0 (terrible) to 10 (excellent). A lower score indicates better sleep. |
| Secondary | Aortic Augmentation (AP, mmHg) | 8 weeks | Measured using radial artery tonometry |
| Secondary | Aortic Augmentation Index (AP/PP, %) | 8 weeks | Measured using radial artery tonometry |
| Secondary | Letter Comparison test of cognitive function | 8 weeks | Measuring reaction time (ms) and accuracy (%) |
| Secondary | Backwards Digit Span test of cognitive function | 8 weeks | Measuring the longest correct span score (higher score = better working memory) |
| Secondary | Stroop Colour Word test of cognitive function | 8 weeks | Measuring congruent/incongruent/neutral reaction time (ms) |
| Secondary | Stroop Colour Word test of cognitive function | 8 weeks | Measuring the Interference Effect (calculated as incongruent reaction time - congruent reaction time) |
| Secondary | Quality of life assessed by the 36-Item Short Form Survey Instrument (SF-36) | 8 weeks | A total score is calculated as a percentage |
| Secondary | Gastrointestinal (GI) Comfort measured via a Likert Scale under 3 conditions | 8 weeks | Participants select one option on the Likert scale ranging from 1 (no GI discomfort) to 4 (lots/frequent/extreme GI discomfort). There is a Likert Scale for each of the following conditions: GI discomfort right now, GI discomfort frequency in the last 8 weeks, and GI discomfort severity in the last 8 weeks. |
| Secondary | Menstrual cycle/menopause symptom questionnaire | 8 weeks | The questionnaire assesses 12 common menstrual cycle/menopause symptoms. Participants rate the severity (0 = none, to 3 = severe) and frequency (0 = never, to 3 = often) of these symptoms. A higher score indicates worse menstrual cycle/menopause symptoms |
| Secondary | Fatty acid blood profile | 8 weeks | |
| Secondary | Body mass (kg) | 8 weeks | |
| Secondary | Fat mass (kg) | 8 weeks | Measured in kilograms and as a fat percentage (%) |
| Secondary | Fat free mass (kg) | 8 weeks | |
| Secondary | Skeletal muscle mass (kg) | 8 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07740967/registered